Skip Ribbon Commands
Skip to main content

 


Protect Your Patients—Secure Your Practice with PtProtect®

Opioid analgesics have a legitimate and important role to manage chronic pain. Yet the use and abuse of prescription medications is a growing problem throughout the United States.

An accurate determination of a patient's medication intake is critical to patient safety. Our most recent data for 2012 shows that 40.1 percent of the time, a patient's urine drug test result will disclose information not explained by the patient's known pain medication prescriptions.

With PtProtect, you get the confidence and reliability you need to ensure successful pain medication monitoring:

Comprehensive

Detects up to 38 prescribed medications and illicit drugs, reducing the possibility of adverse drug reactions and identifying potential diversion of medications.

Sensitive

Uses Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) and the lowest available detection thresholds for the most accurate and sensitive opiate/opioid testing. Our data shows that up to 30 percent of drugs found by LC/MS/MS would have been missed using conventional immunoassay screens for opiates and opioids.

Interpretive

Analytical reports and easy-to-understand interpretive comments eliminate guesswork and save you time.

The PtProtect difference:

– Monitors analgesic medication adherence to ensure patient safety and protect your practice
– Uses lowest detection thresholds for the most sensitive, comprehensive detection of opiates
   and opioids
– Offers highest testing specificity available
– Expert toxicologists available for consult
– Nine comprehensive panel configurations detect up to 38 prescribed medications and illicit drugs
– Detects non-prescribed analgesic medication, reducing the possibility of adverse drug interactions
– Employs LC/MS/MS technology to detect opiates and opioids, avoiding false negatives that may
   result from an immunoassay screen test
– Simplifies patient management with easy-to-understand interpretations in addition to
   quantitative results

 

Find Out More:

Physician Update - PtProtect Pain Medication Management Program.pdf

New Washington State Pain Rules

Patient Care

Testing

Results Interpretation

Expertise

Case Studies

Resources

Frequently Asked Questions


Media and Press Attention

Catholic Health World (National publication, Nov. 19, 2012)

Register Guard newspaper "YOUR HEALTH: New test better detects drug abuse"
(Eugene, Ore., Sept. 27, 2012)

Health Today community publication, Whatcom County, Wash., Fall 2012
“Innovation Helps Save Lives”

The Daily News newspaper (Longview, Wash., June 11, 2012)

KGMI News Reporting (June 4, 2012)

Jefferson Exchange radio interview with Ran Whitehead, CEO and Grant Beardsley,
Clinical Toxicologist (Southern Ore., June 4, 2012)

Register Guard newspaper (Eugene, Ore., May 30, 2012)

National Press Release (Springfield, Ore., May 30, 2012)


Media Resources

Video from the Central Laboratory in Springfield, Oregon

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​